DNA methylation status of a distinctively different subset of genes is associated with each histologic Lauren classification subtype in early gastric carcinogenesis

Oncology Reports

Volumn 31, Issue 6, 2014, Pages 2535-2544

  Chong, Yosep ^a   Mia jan, Khalilullah ^a   Ryu, Hoon ^a   Abdul Ghafar, Jamshid ^a   Munkhdelger, Jijgee ^a   Lkhagvadorj, Sayamaa ^a   Jung, So Young ^a   Lee, Mira ^a   Ji, Sun Young ^a   Choi, Eunhee ^a   Cho, Mee Yon ^a  

^a Yonsei University Wonju   (South Korea)

Author keywords

DNA methylation; Genetic markers; Neoplasms by histologic type; Stomach; Stomach neoplasm

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CCDC57 GENE; CLINICAL ARTICLE; CLIP4 GENE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; EARLY CANCER; FEMALE; GENE IDENTIFICATION; GENETIC ANALYSIS; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MAML3 GENE; PRIORITY JOURNAL; PYROSEQUENCING; SDC2 GENE; STOMACH CARCINOGENESIS; TUMOR GENE; TUMOR LOCALIZATION; XKR6 GENE; ADENOCARCINOMA; CARCINOGENESIS; CLASSIFICATION; GENETICS; HELICOBACTER PYLORI; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED; PATHOLOGY; PROMOTER REGION; STOMACH TUMOR; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOGENESIS; CPG ISLANDS; DNA METHYLATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 84902133374     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3133     Document Type: Article

References (47)

1. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA and Hamilton SM: Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 241: 27-39, 2005. (Pubitemid 40044837)
2. Sapari NS, Loh M, Vaithilingam A and Soong R: Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One 7: e36275, 2012.
3. Shin A, Kim J and Park S: Gastric cancer epidemiology in Korea. J Gastric Cancer 11: 135-140, 2011.
4. Inoue M and Tsugane S: Epidemiology of gastric cancer in Japan. Postgrad Med J 81: 419-424, 2005. (Pubitemid 41002579)
5. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M and Nakayama H: Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 8: 86-94, 2005. (Pubitemid 40655517)
6. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
7. Tan IB, Ivanova T, Lim KH, et al: Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 141: 476-485, 2011.
8. Zheng HC, Li XH, Hara T, et al: Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch 452: 525-534, 2008.
9. Ackerman LV and Rosai J: Rosai and Ackerman's Surgical Pathology. 9th edition. Mosby, St. Louis, MO, 2004.
10. Bosman FT and World Health Organization International Agency for Research on Cancer: WHO Classification of Tumors of the Digestive System. International Agency for Research on Cancer. 4th edition. IARC Press, Lyon, 2010.
11. Oue N, Mitani Y, Motoshita J, et al: Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer 106: 1250-1259, 2006. (Pubitemid 43363901)
12. Yamamoto E, Suzuki H, Takamaru H, Yamamoto H, Toyota M and Shinomura Y: Role of DNA methylation in the development of diffuse-type gastric cancer. Digestion 83: 241-249, 2011.
13. Choi J, Cho MY, Jung SY, Jan KM and Kim HS: CpG island methylation according to the histologic patterns of early gastric adenocarcinoma. Korean J Pathol 45: 469-476, 2011.
14. Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C and Fuks F: Evaluation of the Infinium Methylation 450K technology. Epigenomics 3: 771-784, 2011.
15. Hong SJ, Kang MI, Oh JH, et al: DNA methylation and expression patterns of key tissue-specific genes in adult stem cells and stomach tissues. J Korean Med Sci 24: 918-929, 2009.
16. Zhao C and Bu X: Promoter methylation of tumor-related genes in gastric carcinogenesis. Histol Histopathol 27: 1271-1282, 2012.
17. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
18. Dittmer J: The biology of the Ets1 proto-oncogene. Mol Cancer 2: 29, 2003.
19. Tsutsumi S, Kuwano H, Nagashima N, Shimura T, Mochiki E and Asao T: Ets-1 expression in gastric cancer. Hepatogastroenterology 52: 654-656, 2005. (Pubitemid 40469488)
20. Yu Y, Zhang YC, Zhang WZ, et al: Ets1 as a marker of malignant potential in gastric carcinoma. World J Gastroenterol 9: 2154-2159, 2003. (Pubitemid 37321435)
21. Lind GE, Danielsen SA, Ahlquist T, et al: Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Mol Cancer 10: 85, 2011.
22. Oster B, Thorsen K, Lamy P, et al: Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancer 129: 2855-2866, 2011.
23. Chandrasekaran EV, Lakhaman SS, Chawda R, Piskorz CF, Neelamegham S and Matta KL: Identification of physiologically relevant substrates for cloned Gal: 3-O-sulfotransferases (Gal3STs): distinct high affinity of Gal3ST-2 and LS180 sulfotransferase for the globo H backbone, Gal3ST-3 for N-glycan multiterminal Galß1, 4GlcNAcß units and 6-sulfoGalß1, 4GlcNAcaß, and Gal3ST-4 for the mucin core-2 trisaccharide. J Biol Chem 279: 10032-10041, 2004. (Pubitemid 38372606)
24. Seko A, Nagata K, Yonezawa S and Yamashita K: Down-regulation of Gal 3-O-sulfotransferase-2 (Gal3ST-2) expression in human colonic non-mucinous adenocarcinoma. Jpn J Cancer Res 93: 507-515, 2002. (Pubitemid 34752907)
25. Shi BZ, Hu P, Geng F, He PJ and Wu XZ: Gal3ST-2 involved in tumor metastasis process by regulation of adhesion ability to selectins and expression of integrins. Biochem Biophys Res Commun 332: 934-940, 2005. (Pubitemid 40798177)
26. Cheong TC, Shin JY and Chun KH: Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents. Cancer Sci 101: 94-102, 2010.
27. Kim SJ, Choi IJ, Cheong TC, et al: Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 138: 1035-1045, 2010.
28. Kim SJ, Shin JY, Lee KD, et al: Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1). PLoS One 6: e25103, 2011.
29. Kwak JE, Kim HS, Joo M, Chang SH, Shim SH and Lee HR: The expression of galectin-3 and galectin-7 in epithelial dysplasia and adenocarcinoma of the stomach. Korean J Pathol 42: 365-372, 2008.
30. Saito Y, Sekine W, Sano R, et al: Potentiation of cell invasion and matrix metalloproteinase production by α3β1 integrin-mediated adhesion of gastric carcinoma cells to laminin-5. Clin Exp Metastasis 27: 197-205, 2010.
31. Takatsuki H, Komatsu S, Sano R, Takada Y and Tsuji T: Adhesion of gastric carcinoma cells to peritoneum mediated by α3β1 integrin (VLA-3). Cancer Res 64: 6065-6070, 2004. (Pubitemid 39129405)
32. Ura H, Denno R, Hirata K, Yamaguchi K and Yasoshima T: Separate functions of α2β1 and α3β1 integrins in the metastatic process of human gastric carcinoma. Surg Today 28: 1001-1006, 1998. (Pubitemid 28482054)
33. Adachi M, Taki T, Huang C, et al: Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. J Clin Oncol 16: 1060-1067, 1998. (Pubitemid 28108741)
34. Hashida H, Takabayashi A, Tokuhara T, et al: Integrin α3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82. Int J Cancer 97: 518-525, 2002. (Pubitemid 34027813)
35. Kurokawa A, Nagata M, Kitamura N, et al: Diagnostic value of integrin α3, β4, and β5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma. Cancer 112: 1272-1281, 2008. (Pubitemid 351429742)
36. Zhu GH, Huang C, Qiu ZJ, et al: Expression and prognostic significance of CD151, c-Met, and integrin alpha3/alpha6 in pancreatic ductal adenocarcinoma. Dig Dis Sci 56: 1090-1098, 2011.
37. Park SY, Kook MC, Kim YW, Cho NY, Kim TY and Kang GH: Mixed-type gastric cancer and its association with high- frequency CpG island hypermethylation. Virchows Arch 456: 625-633, 2010.
38. Alves MK, Ferrasi AC, Lima VP, Ferreira MV, de Moura Campos Pardini MI and Rabenhorst SH: Inactivation of COX-2, HMLH1 and CDKN2A genes by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype. Pathobiology 78: 266-276, 2011.
39. Alves MK, Lima VP, Ferrasi AC, Rodrigues MA, De Moura Campos Pardini MI and Rabenhorst SH: CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas. APMIS 118: 297-307, 2010.
40. Dong CX, Deng DJ, Pan KF, et al: Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study. Int J Cancer 124: 434-439, 2009.
41. Kang GH, Lee S, Cho NY, et al: DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Lab Invest 88: 161-170, 2008. (Pubitemid 351161274)
42. Maekita T, Nakazawa K, Mihara M, et al: High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989-995, 2006. (Pubitemid 43259882)
43. Peterson AJ, Menheniott TR, O'Connor L, et al: Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans. Gastroenterology 139: 2005-2017, 2010.
44. Essner JJ, Chen E and Ekker SC: Syndecan-2. Int J Biochem Cell Biol 38: 152-156, 2006. (Pubitemid 41619444)
45. Han I, Park H and Oh ES: New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells. J Mol Histol 35: 319-326, 2004. (Pubitemid 40585317)
46. Bai F, Guo X, Yang L, et al: Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation. Dig Dis Sci 52: 1571-1578, 2007. (Pubitemid 46776502)
47. Budarf ML, Goyette P, Boucher G, et al: A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun 12: 51-58, 2011.